Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer (NCT07281599)
🩺 Plain-English Summary (8th-Grade Level)
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing. The same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.
Who can join: Review the eligibility criteria below.
Location: Planned Parenthood of Southern New England — New Haven, Connecticut
Age range: 25 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Planned Parenthood of Southern New England — New Haven, Connecticut
- Planned Parenthood North Central States — Minneapolis, Minnesota
- Planned Parenthood of Greater Ohio (PPGOH) — Akron, Ohio
📞 Contact the Study Coordinator
Phone: (833) 367-7846
Email: care@qvin.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HPV Infection
- Intradermal, Fractional Dose of HPV Vaccines: — Seattle, Washington
- Immunogenicity of Fractional Dose of the HPV Vaccines — Seattle, Washington
- An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen — Boston, Massachusetts
- Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV — Rockville, Maryland
- Feasibility of HPV Testing With Mail-delivered Sample Collection Kits — San Francisco, California
- PCOM2 - The Physician Communication Intervention, Version 2.0 — Aurora, Colorado
Explore by condition: All HPV Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.